Dr. Gino K. In
Claim this profileUSC / Norris Comprehensive Cancer Center
Expert in Skin Cancer
Studies Melanoma
17 reported clinical trials
29 drugs studied
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
BRAF positive
2Melanoma
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Gino K. In is currently running
OBX-115
for Skin Cancer
This trial tests a new treatment called OBX-115 for adults with advanced solid tumors. It aims to see if the treatment is safe and effective by measuring its ability to shrink tumors, control disease progression, and improve survival.
Recruiting1 award Phase 1 & 211 criteria
Immunotherapy + Prednisone + Sirolimus
for Skin Cancer
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.
Recruiting1 award Phase 1 & 210 criteria
More about Gino K. In
Clinical Trial Related7 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Gino K. In has experience with
- Nivolumab
- Avelumab
- Pembrolizumab
- Cemiplimab
- Ipilimumab
- Resection
Breakdown of trials Gino K. In has run
Skin Cancer
Melanoma
Squamous Cell Carcinoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gino K. In specialize in?
Gino K. In focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Gino K. In currently recruiting for clinical trials?
Yes, Gino K. In is currently recruiting for 10 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Gino K. In has studied deeply?
Yes, Gino K. In has studied treatments such as Nivolumab, Avelumab, Pembrolizumab.
What is the best way to schedule an appointment with Gino K. In?
Apply for one of the trials that Gino K. In is conducting.
What is the office address of Gino K. In?
The office of Gino K. In is located at: USC / Norris Comprehensive Cancer Center, Los Angeles, California 90033 United States. This is the address for their practice at the USC / Norris Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.